Jubilant Ingrevia shares are likely to remain in focus after the company’s board approved a binding term sheet to acquire a 40% strategic stake in Zettaone Technologies India for approximately ₹189.2 crore. After completion, Zettaone will become an associate company of Jubilant Ingrevia. The acquisition will be completed in two tranches, with the first expected by November 2026 and the second by September 2027. The acquisition comes after a strong June quarter for Jubilant Ingrevia. The company reported a 41% year-on-year rise in consolidated net profit, while revenue from operations increased 25.3%. EBITDA also grew 40% year-on-year, indicating strong operating performance during the quarter. In the previous trading session, Jubilant Ingrevia closed at ₹725.90, down ₹6.40. The stock’s 52-week high stands at ₹794.95, recorded on July 22, 2026, placing it around 8.69% below the peak. The company currently has a market capitalisation of approximately ₹11,562 crore.

#StockInNews

457 likes·55 comments